ES8608922A1 - Un metodo para reducir el caracter laminar de una poblacion de liposomas - Google Patents

Un metodo para reducir el caracter laminar de una poblacion de liposomas

Info

Publication number
ES8608922A1
ES8608922A1 ES544364A ES544364A ES8608922A1 ES 8608922 A1 ES8608922 A1 ES 8608922A1 ES 544364 A ES544364 A ES 544364A ES 544364 A ES544364 A ES 544364A ES 8608922 A1 ES8608922 A1 ES 8608922A1
Authority
ES
Spain
Prior art keywords
liposomes
extrusion techniques
producing
producing liposomes
size distribution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES544364A
Other languages
English (en)
Spanish (es)
Other versions
ES544364A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Elan Pharmaceuticals LLC
Original Assignee
Liposome Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liposome Co Inc filed Critical Liposome Co Inc
Publication of ES544364A0 publication Critical patent/ES544364A0/es
Publication of ES8608922A1 publication Critical patent/ES8608922A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/14—Ultrafiltration; Microfiltration
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/14—Ultrafiltration; Microfiltration
    • B01D61/18—Apparatus therefor
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D63/00—Apparatus in general for separation processes using semi-permeable membranes
    • B01D63/08—Flat membrane modules

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Water Supply & Treatment (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
ES544364A 1984-06-20 1985-06-19 Un metodo para reducir el caracter laminar de una poblacion de liposomas Expired ES8608922A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62269084A 1984-06-20 1984-06-20
US62250284A 1984-06-20 1984-06-20

Publications (2)

Publication Number Publication Date
ES544364A0 ES544364A0 (es) 1986-09-01
ES8608922A1 true ES8608922A1 (es) 1986-09-01

Family

ID=27089214

Family Applications (1)

Application Number Title Priority Date Filing Date
ES544364A Expired ES8608922A1 (es) 1984-06-20 1985-06-19 Un metodo para reducir el caracter laminar de una poblacion de liposomas

Country Status (11)

Country Link
EP (1) EP0185756B1 (enExample)
JP (1) JP2537186B2 (enExample)
CA (1) CA1264668C (enExample)
DE (1) DE3579426D1 (enExample)
DK (1) DK173397B1 (enExample)
ES (1) ES8608922A1 (enExample)
GR (1) GR851485B (enExample)
IE (1) IE58630B1 (enExample)
PT (1) PT80678B (enExample)
SG (1) SG21092G (enExample)
WO (1) WO1986000238A1 (enExample)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5231112A (en) * 1984-04-12 1993-07-27 The Liposome Company, Inc. Compositions containing tris salt of cholesterol hemisuccinate and antifungal
US5897873A (en) * 1984-04-12 1999-04-27 The Liposome Company, Inc. Affinity associated vaccine
US5736155A (en) * 1984-08-08 1998-04-07 The Liposome Company, Inc. Encapsulation of antineoplastic agents in liposomes
US5077056A (en) * 1984-08-08 1991-12-31 The Liposome Company, Inc. Encapsulation of antineoplastic agents in liposomes
US5059421A (en) * 1985-07-26 1991-10-22 The Liposome Company, Inc. Preparation of targeted liposome systems of a defined size distribution
MX9203291A (es) * 1985-06-26 1992-08-01 Liposome Co Inc Metodo para acoplamiento de liposomas.
US5041278A (en) * 1985-10-15 1991-08-20 The Liposome Company, Inc. Alpha tocopherol-based vesicles
US4737323A (en) * 1986-02-13 1988-04-12 Liposome Technology, Inc. Liposome extrusion method
US6759057B1 (en) 1986-06-12 2004-07-06 The Liposome Company, Inc. Methods and compositions using liposome-encapsulated non-steroidal anti-inflammatory drugs
US5252263A (en) * 1986-06-16 1993-10-12 The Liposome Company, Inc. Induction of asymmetry in vesicles
US6406713B1 (en) 1987-03-05 2002-06-18 The Liposome Company, Inc. Methods of preparing low-toxicity drug-lipid complexes
US5616334A (en) * 1987-03-05 1997-04-01 The Liposome Company, Inc. Low toxicity drug-lipid systems
CA1338702C (en) * 1987-03-05 1996-11-12 Lawrence D. Mayer High drug:lipid formulations of liposomal- antineoplastic agents
MX9203808A (es) * 1987-03-05 1992-07-01 Liposome Co Inc Formulaciones de alto contenido de medicamento: lipido, de agentes liposomicos-antineoplasticos.
EP0414663A4 (en) * 1987-04-16 1991-07-17 The Liposome Company, Inc. Liposome continuous size reduction method and apparatus
US5262168A (en) * 1987-05-22 1993-11-16 The Liposome Company, Inc. Prostaglandin-lipid formulations
KR970005171B1 (ko) * 1987-05-22 1997-04-14 더 리포조옴 캄파니, 인코포레이티드 아라키돈산 대사물질 관련 리포좀 제조방법 및 그 제제
US5925375A (en) * 1987-05-22 1999-07-20 The Liposome Company, Inc. Therapeutic use of multilamellar liposomal prostaglandin formulations
MX9203804A (es) * 1987-10-19 1992-07-01 Liposome Co Inc Sistemas farmaceuticos a base de tocoferol.
US5948441A (en) * 1988-03-07 1999-09-07 The Liposome Company, Inc. Method for size separation of particles
DE3812816A1 (de) * 1988-04-16 1989-11-02 Lawaczeck Ruediger Dipl Phys P Verfahren zur solubilisierung von liposomen und/oder biologischer membranen sowie deren verwendung
EP0442962B1 (en) * 1988-11-09 1994-01-05 UNGER, Evan C Liposomal radiologic contrast agents
US5049392A (en) * 1989-01-18 1991-09-17 The Liposome Company, Inc. Osmotically dependent vesicles
DE69026380T2 (de) * 1989-06-23 1996-10-17 The Liposome Co.,Inc., Princeton, N.J. Zielliposomen und verfahren zur kupplung von liposomen-proteinen
US5580575A (en) * 1989-12-22 1996-12-03 Imarx Pharmaceutical Corp. Therapeutic drug delivery systems
US5149319A (en) * 1990-09-11 1992-09-22 Unger Evan C Methods for providing localized therapeutic heat to biological tissues and fluids
US5542935A (en) * 1989-12-22 1996-08-06 Imarx Pharmaceutical Corp. Therapeutic delivery systems related applications
US5469854A (en) * 1989-12-22 1995-11-28 Imarx Pharmaceutical Corp. Methods of preparing gas-filled liposomes
US20020150539A1 (en) 1989-12-22 2002-10-17 Unger Evan C. Ultrasound imaging and treatment
US5352435A (en) * 1989-12-22 1994-10-04 Unger Evan C Ionophore containing liposomes for ultrasound imaging
US5820848A (en) * 1990-01-12 1998-10-13 The Liposome Company, Inc. Methods of preparing interdigitation-fusion liposomes and gels which encapsulate a bioactive agent
US5525232A (en) * 1990-03-02 1996-06-11 The Liposome Company, Inc. Method for entrapment of cationic species in lemellar vesicles
AU660288B2 (en) * 1990-07-31 1995-06-22 Transave, Inc. Accumulation of amino acids and peptides into liposomes
US6623671B2 (en) 1990-10-05 2003-09-23 Royden M. Coe Liposome extrusion process
DE69118708T2 (de) * 1990-10-05 1996-10-31 The Liposome Co.,Inc., Princeton, N.J. Extrudierverfahren für liposomen
US5205290A (en) 1991-04-05 1993-04-27 Unger Evan C Low density microspheres and their use as contrast agents for computed tomography
EP0804944A3 (en) 1992-05-04 1998-08-26 UNGER, Evan C A method of providing a gas composition in a biological tissue or fluid in vivo
EP0665756A1 (de) * 1992-10-16 1995-08-09 SACHSE, Andreas Verfahren und vorrichtung zur herstellung flüssiger, disperser systeme
DE69429511T2 (de) * 1993-05-21 2002-05-16 The Liposome Co., Inc. Reduzierung von durch liposome induzierte physiologischen gegenreaktionen
US7083572B2 (en) 1993-11-30 2006-08-01 Bristol-Myers Squibb Medical Imaging, Inc. Therapeutic delivery systems
US5716526A (en) * 1994-01-14 1998-02-10 The Liposome Company, Inc. Method of separating materials from liposomes or lipid complexes
US5622715A (en) * 1994-06-10 1997-04-22 Yissum Research Development Company Of The Hebrew University Of Jerusalem Method of improving renal function
US6235308B1 (en) 1994-06-10 2001-05-22 Yissum Research Development Company Of The Hebrew University Of Jerusalem Method of treating hypertension
DE19515163C2 (de) * 1995-01-31 2002-11-28 Erich Politsch Vorrichtung zur Extrusion von Suspensionen
US5902604A (en) * 1995-06-06 1999-05-11 Board Of Regents, The University Of Texas System Submicron liposome suspensions obtained from preliposome lyophilizates
US6521211B1 (en) 1995-06-07 2003-02-18 Bristol-Myers Squibb Medical Imaging, Inc. Methods of imaging and treatment with targeted compositions
NL1001380C2 (nl) * 1995-10-09 1997-04-11 Fuji Photo Film Bv Methode voor het dispergeren van een geëmulgeerd materiaal van het olie-druppeltype in een vloeistoftoevoersysteem en bekledingsmethode waarbij van een dergelijke dispergeermethode gebruik wordt gemaakt.
EP0801557B1 (en) 1995-10-12 2003-07-02 Supergen, Inc. Liposome formulations of 5beta steroids
DE19542499A1 (de) 1995-11-15 1997-05-22 Bayer Ag Verfahren und Vorrichtung zur Herstellung einer parenteralen Arzneistoffzubereitung
EP0935415B1 (en) 1996-05-01 2006-11-22 Imarx Pharmaceutical Corp. In vitro methods for delivering nucleic acids into a cell
US5846517A (en) 1996-09-11 1998-12-08 Imarx Pharmaceutical Corp. Methods for diagnostic imaging using a renal contrast agent and a vasodilator
IT1289939B1 (it) * 1997-02-20 1998-10-19 Angelini Ricerche Spa Composizione farmaceutica acquosa comprendente un principio attivo altamente insolubile in acqua
US6537246B1 (en) 1997-06-18 2003-03-25 Imarx Therapeutics, Inc. Oxygen delivery agents and uses for the same
US7452551B1 (en) 2000-10-30 2008-11-18 Imarx Therapeutics, Inc. Targeted compositions for diagnostic and therapeutic use
US20010003580A1 (en) 1998-01-14 2001-06-14 Poh K. Hui Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
DE60229118D1 (de) 2001-04-04 2008-11-13 Nordic Vaccine Technology As Polynukleotide-bindende komplexe die sterolen und saponine enthalten
DK1560641T3 (da) 2002-11-14 2006-07-31 Leuven K U Res & Dev Fremgangsmåde til fremstilling af emulsioner
JP2005170928A (ja) * 2003-10-21 2005-06-30 Konica Minolta Medical & Graphic Inc リポソーム含有ｘ線造影剤およびその製造方法
JP2005170923A (ja) * 2003-10-21 2005-06-30 Konica Minolta Medical & Graphic Inc リポソーム含有ｘ線造影剤およびその製造方法
JP4654590B2 (ja) * 2004-03-31 2011-03-23 コニカミノルタエムジー株式会社 Ｘ線ｃｔ用造影組成物およびその製造方法
EP2020988B1 (en) 2006-04-28 2017-08-16 Children's Hospital Medical Center Compositions comprising fusogenic proteins or polypeptides derived from prosaposin for application in transmembrane drug delivery systems
KR20080012605A (ko) 2006-08-04 2008-02-12 삼성에스디아이 주식회사 탄성 에너지 장벽을 이용한 생체막 소자
EP1920765A1 (en) * 2006-11-07 2008-05-14 Medigene AG Liposome preparation by single-pass process
US9445975B2 (en) * 2008-10-03 2016-09-20 Access Business Group International, Llc Composition and method for preparing stable unilamellar liposomal suspension
JP5771366B2 (ja) 2009-09-02 2015-08-26 株式会社バイオメッドコア リポソーム製造装置及び方法
US20120310140A1 (en) 2010-12-01 2012-12-06 Spinal Modulation, Inc. Directed delivery of agents to neural anatomy
JP2015509085A (ja) 2012-01-01 2015-03-26 キュービーアイ エンタープライゼズ リミテッドＱｂｉ Ｅｎｔｅｒｐｒｉｓｅｓ Ｌｔｄ． 治療剤および診断剤の選択的送達のためのｅｎｄｏ１８０を標的とする粒子
ES2874305T3 (es) * 2013-03-14 2021-11-04 Zuli Holdings Ltd Formulación y fabricación de liposomas
US9993427B2 (en) 2013-03-14 2018-06-12 Biorest Ltd. Liposome formulation and manufacture
US11246832B2 (en) * 2016-06-28 2022-02-15 Verily Life Sciences Llc Serial filtration to generate small cholesterol-containing liposomes
JP6403026B2 (ja) * 2017-06-29 2018-10-10 バイオレスト リミテッド リポソーム、リポソームを含む処方剤、および処方剤の製造方法
KR102923958B1 (ko) 2017-12-15 2026-02-06 더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 엑소좀 관련 유전자 편집을 이용한 암 치료 방법 및 조성물
JP7474702B2 (ja) 2018-03-28 2024-04-25 ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム エキソソームから単離されたｄｎａにおけるエピジェネティック変化の同定法
JP6596648B2 (ja) * 2018-08-29 2019-10-30 ズーリー ホールディングス リミテッド リポソーム、リポソームを含む処方剤、および処方剤の製造方法
WO2024175457A1 (en) * 2023-02-23 2024-08-29 Evonik Operations Gmbh Small scale liposome extruder

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5186117A (en) * 1975-01-27 1976-07-28 Tanabe Seiyaku Co Johoseibiryushiseizainoseiho
US4263428A (en) * 1978-03-24 1981-04-21 The Regents Of The University Of California Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same
CA1173360A (en) * 1979-06-22 1984-08-28 Jurg Schrank Pharmaceutical preparations
JPS5782310A (en) * 1980-11-11 1982-05-22 Tanabe Seiyaku Co Ltd Production of liposome preparation

Also Published As

Publication number Publication date
ES544364A0 (es) 1986-09-01
WO1986000238A1 (en) 1986-01-16
DK77986A (da) 1986-02-19
CA1264668A (en) 1990-01-23
DK173397B1 (da) 2000-09-18
DK77986D0 (da) 1986-02-19
EP0185756B1 (en) 1990-08-29
PT80678B (pt) 1987-08-19
CA1264668C (en) 1990-01-23
JP2537186B2 (ja) 1996-09-25
SG21092G (en) 1992-04-16
DE3579426D1 (de) 1990-10-04
IE58630B1 (en) 1993-10-20
EP0185756A4 (en) 1987-09-02
JPS61502452A (ja) 1986-10-30
IE851514L (en) 1985-12-20
PT80678A (en) 1985-07-01
GR851485B (enExample) 1985-11-25
EP0185756A1 (en) 1986-07-02

Similar Documents

Publication Publication Date Title
ES8608922A1 (es) Un metodo para reducir el caracter laminar de una poblacion de liposomas
AU536477B2 (en) Type 22 interferon production
IT8423568A1 (it) Procedimento per la preparazione di vagli molecolari con l'uso di stampi imidazolici
CA2039315A1 (en) Human hematopoietic stem cell
GB2092189B (en) Producing synthetic yarn and yarn-like structures
AU535313B2 (en) Sorting objects according to destination
DE68926758D1 (de) Abriebfeste gesinterte Eisenlegierung, bestehend aus einer Dispersion von harten Legierungsteilchen und Verfahren zu ihrer Herstellung
GB2086870B (en) High performance carbon fiber process for production thereof and composite materials prepared therewith
IT8149520A0 (it) Procedimento per la preparazione di sospensioni stabili e non gelificabili in particolare per la produzione di detersivi in granuli
EP0334478A3 (en) Die-upset manufacture to produce high volume fractions of re-fe-b type magnetically-aligned material
GB8425961D0 (en) Producing fine fibres
IT8149760A0 (it) Dibenzazepine loro preparazione eloro impiego come medicamenti
DE3175184D1 (en) 2,3-butanediol diester derivatives, process for producing the same, and an antiulcer drug containing the same
GB2057344B (en) Spinneret assembly for use in production of multi-core composite filamentss
DE3161409D1 (en) 2,4-dialkyl-2,6-heptadienals and -hetadienols, process for their preparation and their use as perfume compounds and flavourings
IL52615A0 (en) Novel 1,5-disubstituted-2-pyrrolidones,their production and pharmaceutical compositions containing them
DE3752106D1 (de) Herstellung von Katalysatorteilchen sortiert nach Dichte
JPS5596095A (en) Composite particle group containing active protein substance * production * use and regeneration thereof
GB8818794D0 (en) Production of intermetallic particles & products including such
EP0043507A3 (en) 2,4-dioxa-7,10 methano-spiro(5,5)undecanes, their preparation as well as perfume compositions containing them
IL61223A (en) Tricyclo(6.2.1.0 1,6)undecanes,their preparation and perfume compositions containing them
ZA839343B (en) Process for the production of dihydrocarbyl carbonates,their use as fuel additives and fuel compositions containing them
ZA807943B (en) New pyrrolobenzotriazepines,their production and pharmaceutical compositions containing them
EP0137426A3 (de) Neue 2-Mercaptothiazolderivate, Verfarhen zu deren Herstellung sowie die Verwendung von 2-Mercaptothiazolderivaten in Arzneimitteln
AU7435587A (en) Fine particle-containing fibers and process for their production

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20060605